Microcap Ledger

Tickers · $AMST

Amesite Inc. $AMST

By Microcap Ledger desk · CIK 0001807166

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
Nasdaq Capital Market
Sector
Services-Prepackaged Software
Headquarters
Ann Arbor, MI
Fiscal year end
June 30
Shares outstanding
6,549,851 [10-K 2026-09-23]
as of 2026-09-23

Sources: [10-K 2026-09-23]

What the company doesAI summary of filing

Amesite is a technology company that develops and sells artificial intelligence-powered software solutions for the healthcare industry, with a focus on the post-acute care market. The company operates two main product lines: NurseMagic™, which serves both individual healthcare professionals (B2C) and healthcare businesses including home health, skilled nursing, and hospice operations (B2B), and LynkMagic™, which provides enterprise AI solutions for healthcare organizations. The company generates revenue through subscription-based pricing tiers for NurseMagic™ and enterprise deployments of LynkMagic™, with individual users able to access a free version of NurseMagic™. As of fiscal 2026, the company is revenue-generating and deployed its largest enterprise implementation to date, serving approximately 2,700-patient census. [10-K 2026-09-23]

Segments: NurseMagic™ (B2C), NurseMagic™ (B2B), LynkMagic™, Amesite Engage

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
FY ended Jun 2026$364.8K−$3.10M −$2.15M$2.30M[10-K 2026-09-23]
FY ended Jun 2025$110.5K−$6.62M −$2.46M$2.33M[10-K 2026-09-23]
Quarterly cash burn
−$536.7K
Cash runway Estimate
~12.9 months

Estimate: cash at the end of the period (FY ended Jun 2026) divided by the average monthly operating cash outflow over that period. Ignores any cash raised or spent since, and any financing.

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2024-11-142,792,440[10-Q/A 2025-01-02]
2025-02-053,994,107[10-Q 2025-02-07]
2025-05-154,572,713[10-Q 2025-05-15]
2025-09-294,572,713[10-K 2025-09-29]
2025-10-244,572,713[10-K/A 2025-10-28]
2026-02-054,572,713[10-Q 2026-02-06]
2026-05-185,852,985[10-Q 2026-05-18]
2026-09-236,549,851[10-K 2026-09-23]
Shelf registration
S-1 filed 2026-05-12; declared effective 2026-05-28 [S-1 2026-05-12]

Listing status

Current status: 2 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2025-10-29. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

DateEventDetailsDeadlineFiling
2025-10-298-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2025-10-29]
2024-12-038-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2024-12-03]

More on deficiency notices and uplistings: Listing status desk.

Catalysts and calendar

Recent filings and releases
DateTypeTitle
2026-10-02PRE 14AProxy statement
2026-09-2310-KAnnual report
2026-09-178-KOther events
2026-09-118-KRegulation FD disclosure
2026-07-208-KMaterial agreement entered
2026-07-17424B5Prospectus or prospectus supplement
2026-07-138-KDirector or officer change; Shareholder vote results
2026-06-03DEF 14AProxy statement
2026-05-26S-1/ARegistration statement
2026-05-198-KOther events
2026-05-1810-QQuarterly report
2026-05-15NT 10-QNotice of late quarterly report

Facts as of . Small caps move fast; check the latest filings.